Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long-term secondary prevention of venous thromboembolism
Karin Wåhlander; Henry Eriksson; Torbjörn Lundström; Solveig Billing Clason; Ulrika Wall; Per Nyström; Peter Wessman; Sam Schulman; THRIVE III Investigators
- 作者Karin Wåhlander; Henry Eriksson; Torbjörn Lundström; Solveig Billing Clason; Ulrika Wall; Per Nyström; Peter Wessman; Sam Schulman; THRIVE III Investigators
- 卷第133卷
- 期第1期
- 印刷ISSN0007-1048
- 电子ISSN1365-2141
- 文件大小391.03KB
- 发表时间2006
- DOI10.1111/j.1365-2141.2006.05960.x
- 页码68-77